GenSight Biologics Email Formats

Biotechnology Research • Paris, Île-de-France, France • 21-50 Employees

GenSight Biologics Email Formats

GenSight Biologics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@gensight-biologics.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@gensight-biologics.com	50%
{first name}{last name}	johndoe@gensight-biologics.com	50%

Key Contacts at GenSight Biologics

Scott Jeffers

Chief Technology Officer

Laurence Rodriguez

Chief Executive Officer

Serge Fitoussi

Clinical Operation Director

Company overview

Headquarters	74 rue du Faubourg Saint Antoine, Paris, Ile de France 75012, FR
Phone number	+33176217220
Website	gensight-biologics.com
NAICS	541714
SIC	873
Founded	2013
Employees	21-50
Socials

About GenSight Biologics

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in teens and young adults. Using its gene therapy-based approach, GenSight Biologics’ product candidates are designed to be administered in a single treatment to each eye by intravitreal injection to offer patients a sustainable functional visual recovery.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

C-Suite

Manager

Entry

Employees by Department

GenSight Biologics has 12 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore GenSight Biologics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-12-21	14	$5,100,000
2024-03-08	14	$5,400,000
2024-06-07	14	$10,000,000
2024-12-01	14	$3,000,000
2025-01-24	14	$1,600,000
2025-04-07	14	$932,700
2025-07-01	14	$4,500,000
2025-08-17	14	$579,500
2025-10-26	14	$4,300,000

Funding Insights

$35,412,200

Total funding amount

$4,300,000

Most recent funding amount

Number of funding rounds

GenSight Biologics Tech Stack

Discover the technologies and tools that power GenSight Biologics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Ninja Forms

Form builders

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

Microsoft 365

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

WPML

Translation

Frequently asked questions

GenSight Biologics is located in Paris, Île-de-France, FR.

You can reach GenSight Biologics at +33176217220.

GenSight Biologics was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

GenSight Biologics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

GenSight Biologics has raised a total of $35,412,200 across 9 funding rounds. This investment has helped the company grow and expand its operations.